0001822334-20-000003.txt : 20200917 0001822334-20-000003.hdr.sgml : 20200917 20200916182725 ACCESSION NUMBER: 0001822334-20-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200917 DATE AS OF CHANGE: 20200916 EFFECTIVENESS DATE: 20200917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inhalon Biopharma, Inc. CENTRAL INDEX KEY: 0001822334 IRS NUMBER: 831917750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-374195 FILM NUMBER: 201179681 BUSINESS ADDRESS: STREET 1: 106 OAK SPRING COURT CITY: CARRBORO STATE: NC ZIP: 27510 BUSINESS PHONE: (650) 439-0110 MAIL ADDRESS: STREET 1: 106 OAK SPRING COURT CITY: CARRBORO STATE: NC ZIP: 27510 D/A 1 primary_doc.xml X0708 D/A LIVE 0001822334 Inhalon Biopharma, Inc. 106 OAK SPRING COURT CARRBORO NC NORTH CAROLINA 27510 (650) 439-0110 DELAWARE None None Corporation true 2018 John B. Whelan 106 Oak Spring Court Carrboro NC NORTH CAROLINA 27510 Executive Officer Director Samuel Lai 106 Oak Spring Court Carrboro NC NORTH CAROLINA 27510 Executive Officer Director Winnie Wan 106 Oak Spring Court Carrboro NC NORTH CAROLINA 27510 Director Biotechnology Decline to Disclose 06b true 0001822334-20-000002 2020-08-18 false true false 0 Kim, Hyun Tae None None None 113-1006, Haengdang-ro Seongdong-gu Seoul M5 KOREA, REPUBLIC OF 00000 true 3628750 2903725 725025 false 15 0 0 0 false Inhalon Biopharma, Inc. /s/ John B. Whelan John B. Whelan Chief Executive Officer 2020-09-16